Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
USV Expands Diabetes Portfolio with Cost-Effective Liralin-EP in India Deeksha Bhandari22 March 2025 1:00 PM ISTUSV Pvt. Ltd., launches the Liralin EP a combination of Linagliptin & Empagliflozin at just Rs 12.90 per tablet for strengthening it's affordable...
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry Deeksha Bhandari21 March 2025 6:00 PM ISTNew Delhi: Strengthening its leadership in diabetes care, USV Pvt. Ltd. has announced the launch of its Xenia brand range, following...
CDSCO Approves Metformin Use in Pregnancy and Peri-Conceptional Phase Deeksha Bhandari15 Feb 2025 12:00 PM ISTThe Endocrinology and Metabolism Subject Expert Committee (SEC) under CDSCO has approved updating the prescribing information for Metformin...
Latest Update on Metformin - 2025 CDSCO Recommended Grant of Permission for Consideration of Metformin in Pregnancy Deeksha Bhandari30 Jan 2025 12:23 PM ISTThe Central Drugs Standard Control Organization (CDSCO) has granted approval for updating the prescribing information for Metformin Sustained...
Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings MD Brand Connect18 Dec 2024 12:00 PM ISTPresenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin...
SEC Committee Recommends Metformin SR for Gestational Diabetes; Final Approval Pending MDTV Bureau25 Nov 2024 9:00 AM ISTThe Endocrinology & Metabolism Subject Experts Committee (SEC), under the Central Drugs Standard Control Organization (CDSCO), recently reviewed...
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Dapagliflozin Glimepiride Metformin FDC in Uncontrolled T2DM with HbA1c >9 % Dr Rajeev Chawla8 Oct 2024 12:24 PM ISTIntroductionIndia has the second highest rate of diabetes in the world. (1) According to the ICMR-INDIAB-17 study, the prevalence of diabetes in India...
